clinical trial · NCT02402595
Drug Interaction Study Between AVP-923 and Itraconazole and Between AVP-786 and Itraconazole in Healthy Adult Subejcts
Otsuka Pharmaceutical Development & Commercialization, Inc.·phase1·completed·n = 24
HealthyAVP-923AVP-786Itraconazole
brief summary
The purpose of this study is to determine the effects of a potent CYP3A4 inhibitor, itraconazole, on the steady-state PK of AVP-923 and AVP-786.
started
Mar 1, 2015
primary completion
Jul 1, 2015
completion
Jul 1, 2015
last updated
Apr 28, 2026
detailed description
A Phase 1, single-center, randomized, double-blind, double-dummy drug interaction study.
official title
A Phase 1, Single-center, Randomized, Double-blind, Double-dummy, Drug Interaction Study Between AVP-923 and Itraconazole, and Between AVP-786 and Itraconazole in Healthy Adult Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol